17 November 2020 : Original article
Treatment of Antibody-Mediated Rejection After Kidney Transplantation: Immunological Effects, Clinical Response, and Histological Findings
Marcos Vinicius de Sousa1ABCDEF*, Ana Claudia Gonçalez2CD, Ricardo de Lima Zollner3DE, Marilda Mazzali1ADEDOI: 10.12659/AOT.925488
Ann Transplant 2020; 25:e925488
Figure 1 Dynamics of mean fluorescence intensity (MFI) of donor-specific anti-HLA antibodies (DSA) after the treatment of antibody-mediated rejection (AMR) with intravenous immunoglobulin (IVIG) and/or plasmapheresis (PP).